Abstract
This mini-review paper does not consider classical work concerning the formation of inclusion complexes between pharmaceuticals and cyclodextrins. Instead, it highlights recent reports concerning the association of these host:guest systems with other carrier systems such as liposomes and nanoparticles showing the state of art of this subject with examples of developed systems and the advantages of these strategy in order to be potential systems as drug carriers.
Keywords: Cyclodextrin, liposome, nanoparticle, drug delivery.
Current Topics in Medicinal Chemistry
Title:Cyclodextrin Inclusion Complexes Loaded in Particles as Drug Carrier Systems
Volume: 14 Issue: 4
Author(s): Leonardo Fernandes Fraceto, Renato Grillo and Eduardo Sobarzo-Sanchez
Affiliation:
Keywords: Cyclodextrin, liposome, nanoparticle, drug delivery.
Abstract: This mini-review paper does not consider classical work concerning the formation of inclusion complexes between pharmaceuticals and cyclodextrins. Instead, it highlights recent reports concerning the association of these host:guest systems with other carrier systems such as liposomes and nanoparticles showing the state of art of this subject with examples of developed systems and the advantages of these strategy in order to be potential systems as drug carriers.
Export Options
About this article
Cite this article as:
Fraceto Fernandes Leonardo, Grillo Renato and Sobarzo-Sanchez Eduardo, Cyclodextrin Inclusion Complexes Loaded in Particles as Drug Carrier Systems, Current Topics in Medicinal Chemistry 2014; 14 (4) . https://dx.doi.org/10.2174/1568026613666131219124847
DOI https://dx.doi.org/10.2174/1568026613666131219124847 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Phage Display Applications for Molecular Imaging
Current Pharmaceutical Biotechnology Liposomal Muramyl Tripeptide Phosphatidylethanolamine: Targeting and Activating Macrophages for Adjuvant Treatment of Osteosarcoma
Current Cancer Drug Targets Cancer Chemoprevention by Dietary Phytochemicals: Promises and Pitfalls
Current Pharmaceutical Biotechnology Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma
Current Cancer Therapy Reviews Nanomedical Platform for Drug Delivery in Cancer
Current Organic Chemistry Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets PPARγ Agonists in Combination Cancer Therapies
Current Cancer Drug Targets Inhibition of V-ATPase and Carbonic Anhydrases as Interference Strategy with Tumor Acidification Processes
Current Pharmaceutical Design Anticancer Peptides and Proteins: A Panoramic View
Protein & Peptide Letters TGF-β Pathway as a Therapeutic Target in Bone Metastases
Current Pharmaceutical Design Pharmacogenomics of Cytochrome P450 Enzymes in Tumours
Current Pharmacogenomics Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review
Current Neuropharmacology Insights into Targeting Colon Cancer Cell Fate at the Level of Proteoglycans / Glycosaminoglycans
Current Medicinal Chemistry Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications
Anti-Cancer Agents in Medicinal Chemistry The Key microRNAs Regulated the Development of Non-small Cell Lung Cancer by Targeting TGF-β-induced epithelial–mesenchymal Transition
Combinatorial Chemistry & High Throughput Screening Targeting Telomerase by Antisense-Based Approaches: Perspectives for New Anti-Cancer Therapies
Current Pharmaceutical Design BMP-9 Induced Osteogenic Differentiation of Mesenchymal Stem Cells: Molecular Mechanism and Therapeutic Potential
Current Gene Therapy Platelet-Rich Plasma Induces Mixed Osteogenic/Osteoclastogenic Phenotype in Osteosarcoma SaOS-2 Cells: Role of TGF-Beta
Current Pharmaceutical Biotechnology Post-Translational Control of Sp-Family Transcription Factors
Current Genomics Genistein Inhibits Cell Growth and Induces Apoptosis Through Up-regulation of miR-34a in Pancreatic Cancer Cells
Current Drug Targets